FDA Takes Action Against Propoxyphene But Keeps It On The Market

FDA denies Public Citizen's request for withdrawal, instead mandating new studies to assess propoxyphene's link to overdoses and requiring a boxed warning and MedGuide.

More from Archive

More from Pink Sheet